Takeda Pharmaceutical Co Ltd (JP:4502)
:4502
Want to see JP:4502 full AI Analyst Report?
Total Valuation
Takeda Pharmaceutical Co has a market cap or net worth of ¥8.33T. The enterprise value is ¥12.60T.
Market Cap¥8.33T
Enterprise Value¥12.60T
Share Statistics
Takeda Pharmaceutical Co has 1,591,262,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,591,262,500
Owned by Insiders0.16%
Owned by Institutions<0.01%
Financial Efficiency
Takeda Pharmaceutical Co’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 2.95%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)2.95%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee91.43M
Profits Per Employee3.89M
Employee Count49,281
Asset Turnover0.29
Inventory Turnover1.58
Valuation Ratios
The current PE Ratio of Takeda Pharmaceutical Co is 46.5. Takeda Pharmaceutical Co’s PEG ratio is 0.60.
PE Ratio46.5
PS Ratio1.98
PB Ratio1.15
Price to Fair Value1.15
Price to FCF11.70
Price to Operating Cash Flow8.46
PEG Ratio0.60
Income Statement
In the last 12 months, Takeda Pharmaceutical Co had revenue of 4.51T and earned 191.76B in profits. Earnings per share was 121.75.
Revenue4.51T
Gross Profit2.30T
Operating Income540.45B
Pretax Income260.19B
Net Income191.76B
EBITDA1.26T
Earnings Per Share (EPS)121.75
Cash Flow
In the last 12 months, operating cash flow was 971.10B and capital expenditures -188.73B, giving a free cash flow of 782.37B billion.
Operating Cash Flow971.10B
Free Cash Flow782.37B
Free Cash Flow per Share491.67
Dividends & Yields
Takeda Pharmaceutical Co pays an annual dividend of ¥100, resulting in a dividend yield of 4.11%
Dividend Per Share¥100
Dividend Yield4.11%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.42
52-Week Price Change32.09%
50-Day Moving Average5.53K
200-Day Moving Average4.80K
Relative Strength Index (RSI)40.74
Average Volume (3m)4.35M
Important Dates
Takeda Pharmaceutical Co upcoming earnings date is Jul 30, 2026, Before Open (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateJul 30, 2026
Ex-Dividend Date―
Financial Position
Takeda Pharmaceutical Co as a current ratio of 1.27, with Debt / Equity ratio of 62.80%
Current Ratio1.27
Quick Ratio0.70
Debt to Market Cap0.55
Net Debt to EBITDA3.40
Interest Coverage Ratio1.51
Taxes
In the past 12 months, Takeda Pharmaceutical Co has paid 68.16B in taxes.
Income Tax68.16B
Effective Tax Rate0.26
Enterprise Valuation
Takeda Pharmaceutical Co EV to EBITDA ratio is 10.47, with an EV/FCF ratio of 17.32.
EV to Sales2.93
EV to EBITDA10.47
EV to Free Cash Flow17.32
EV to Operating Cash Flow14.07
Balance Sheet
Takeda Pharmaceutical Co has ¥595.05B in cash and marketable securities with ¥4.88T in debt, giving a net cash position of -¥4.29T billion.
Cash & Marketable Securities¥595.05B
Total Debt¥4.88T
Net Cash-¥4.29T
Net Cash Per Share-¥2.69K
Tangible Book Value Per Share-¥922.86
Margins
Gross margin is 58.76%, with operating margin of 11.99%, and net profit margin of 4.26%.
Gross Margin58.76%
Operating Margin11.99%
Pretax Margin5.77%
Net Profit Margin4.26%
EBITDA Margin28.00%
EBIT Margin11.99%
Analyst Forecast
The average price target for Takeda Pharmaceutical Co is ¥6,900.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target¥6,900.00
Price Target Upside63.43% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-1.66%
EPS Growth Forecast78.06%